Dr. Reddy's Laboratories Limited (RDDA) — Financial Flexibility Index
Dr. Reddy's Laboratories Limited (RDDA) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of €18.23 Billion (operating CF €10.91 Billion minus capex €7.32 Billion) represents 0% of total liabilities (€187.14 Billion). Check Dr. Reddy's Laboratories Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Dr. Reddy's Laboratories Limited Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Dr. Reddy's Laboratories Limited across 9 annual periods. For the full cash flow conversion analysis, see Dr. Reddy's Laboratories Limited (RDDA) cash conversion ratio.
Annual Financial Flexibility Index for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year free cash flow to debt coverage for Dr. Reddy's Laboratories Limited. Explore Dr. Reddy's Laboratories Limited debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.52x | €80.83 Billion | €46.43 Billion | €155.82 Billion | ▼ -23.9% |
| 2024 | 0.68x | €72.87 Billion | €45.43 Billion | €106.97 Billion | ▼ -21.1% |
| 2023 | 0.86x | €77.74 Billion | €58.88 Billion | €89.99 Billion | ▲ +114.4% |
| 2022 | 0.40x | €42.77 Billion | €28.11 Billion | €106.13 Billion | ▼ -19.7% |
| 2021 | 0.50x | €45.44 Billion | €35.70 Billion | €90.51 Billion | ▲ +11.8% |
| 2020 | 0.45x | €34.69 Billion | €29.84 Billion | €77.25 Billion | ▲ +7.3% |
| 2019 | 0.42x | €35.66 Billion | €28.70 Billion | €85.23 Billion | ▲ +51.8% |
| 2018 | 0.28x | €27.32 Billion | €18.03 Billion | €99.14 Billion | ▼ -21.9% |
| 2017 | 0.35x | €33.79 Billion | €21.51 Billion | €95.78 Billion | — |